Histological Outcome of Fuzheng Huayu plus Entecavir Combination Therapy in Chronic Hepatitis B Patients with Significant Liver Fibrosis

Background and Aims: To evaluate the efficacy of Fuzheng Huayu (FZHY), a Chinese herbal formula, plus entecavir (ETV) in regression of liver fibrosis in chronic hepatitis B (CHB) patients with significant fibrosis/cirrhosis. Methods: The current study was a two-center, randomized, double-blind and p...

Descripción completa

Detalles Bibliográficos
Autores principales: Gui, Hong-Lian, Zhao, Chang-Qing, Wang, Yan, Gu, Hong-Tu, Wang, Wei-Jing, Cai, Wei, Guo, Qing, Bao, Shi-San, Xu, Lie-Ming, Xie, Qing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: XIA & HE Publishing Inc. 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7562803/
https://www.ncbi.nlm.nih.gov/pubmed/33083250
http://dx.doi.org/10.14218/JCTH.2020.00004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7562803/
https://www.ncbi.nlm.nih.gov/pubmed/33083250
http://dx.doi.org/10.14218/JCTH.2020.00004

Ejemplares similares